###begin article-title 0
###xml 61 62 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 62 62 58 58 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 62 62 58 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 62 62 58 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
TMP21 Transmembrane Domain Regulates gamma-Secretase Cleavage*
###end article-title 0
###begin p 1
Supported by the French National Research Agency. Current address: Institut de Pharmacologie Moleculaire et Cellulaire, CNRS, Equipe Labellisee Fondation pour la Recherche Medicale, Valbonne 06560, France.
###end p 1
###begin p 2
These authors contributed equally to this work.
###end p 2
###begin p 3
Supported by the Wellcome Trust.
###end p 3
###begin p 4
TMP21 has been shown to be associated with the gamma-secretase complex and can specifically regulate gamma-cleavage without affecting ϵ-mediated proteolysis. To explore the basis of this activity, TMP21 modulation of gamma-secretase activity was investigated independent of ϵ-cleavage using an amyloid-beta precursor proteinϵ (APPϵ) construct which lacks the amyloid intracellular domain domain. The APPϵ construct behaves similarly to the full-length precursor protein with respect to alpha- and beta-cleavages and is able to undergo normal gamma-processing. Co-expression of APPϵ and TMP21 resulted in the accumulation of membrane-embedded higher molecular weight Abeta-positive fragments, consistent with an inhibition of gamma-secretase cleavage. The APPϵ system was used to examine the functional domains of TMP21 through the investigation of a series of TMP21-p24a chimera proteins. It was found that chimeras containing the transmembrane domain bound to the gamma-secretase complex and could decrease gamma-secretase proteolytic processing. This was confirmed though investigation of a synthetic peptide corresponding to the TMP21 transmembrane helix. The isolated TMP21 TM peptide but not the homologous p24a domain was able to reduce Abeta production in a dose-dependent fashion. These observations suggest that the TMP21 transmembrane domain promotes its association with the presenilin complex that results in decreased gamma-cleavage activity.
###end p 4
###begin p 5
###xml 282 283 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 282 283 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN6"><sup>5</sup></xref>
###xml 412 413 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 655 656 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 752 753 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 755 756 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 787 788 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 788 788 761 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5"/>
###xml 789 790 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 805 806 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 808 809 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 817 818 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 855 857 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 866 868 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 924 925 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
Alzheimer disease is a progressive neurodegenerative disorder and the most common cause of dementia worldwide. One of the main histopathological hallmarks in Alzheimer disease is senile plaque, an extracellular protein deposit composed primarily of the amyloid beta-peptide (Abeta),5 which is generated by sequential cleavages of the amyloid-beta precursor protein (APP) by beta- and gamma-secretase activities (1). Cleavage by gamma-secretase occurs within the APP transmembrane domain at several sequences, such as the gamma-site, to produce Abeta40/42, and the ϵ-site, which results in the release of the cytosolic amyloid intracellular domain (AICD) (2). AICD is targeted to the nucleus and regulates transcription of several genes including KAI1 (3, 4), glycogen synthase kinase 3 (4-6), neprilysin (7, 8), p53 (9), epidermal growth factor receptor (10), LRP1 (11), Tip60, APP, or beta-site APP-cleaving enzyme (BACE) (4).
###end p 5
###begin p 6
###xml 316 318 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 318 318 314 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13"/>
###xml 318 318 314 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14"/>
###xml 318 318 314 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15"/>
###xml 319 321 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 399 401 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 401 401 393 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18"/>
###xml 402 404 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 501 503 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 505 507 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 509 511 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 735 737 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 739 741 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 829 831 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 920 922 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 924 926 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
Several lines of evidence have shown that gamma/ϵ-secretase activity requires multimeric membrane protein complexes, the presenilin complexes, which are composed of at least four components: presenilin (PS1 or PS2), nicastrin (NCT), anterior pharynx-defective phenotype 1 (APH-1), and presenilin enhancer 2 (PEN-2) (12-16). All four components appear to be essential for gamma/ϵ-secretase activity (17-19). NCT and APH-1 form an initial subcomplex to which full-length PS1 or PS2 and PEN-2 are added (18, 20, 21). During maturation of the presenilin complexes, nicastrin is glycosylated, and presenilins are cleaved into N- and C-terminal fragments which remain associated as a heterodimer in the active high molecular weight complex (20, 22). In these complexes presenilins have been proposed to serve as the catalytic subunit (23), whereas the large ectodomain of NCT plays an essential role in substrate recognition (24, 25).
###end p 6
###begin p 7
###xml 224 226 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 482 484 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
It has been demonstrated that TMP21, a member of p24 cargo protein with homology to p24a, binds the presenilin complexes and acts as a modulator resulting in the selective suppression of gamma- but not ϵ-secretase cleavage (26). TMP21 small interfering RNA suppression enhances the production of Abeta, whereas overexpression or the ablation of TMP21 does not affect AICD production. In this context TMP21 has no effect on p53 or NEP, which are two target genes of AICD activation (27).
###end p 7
###begin p 8
###xml 391 393 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
In the current study, the effects of TMP21 on gamma-secretase activity were investigated independent of ϵ-cleavage using an APPϵ construct which lacks the AICD domain (terminates at Abeta49). The APPϵ fragment behaves similarly to the full-length precursor protein with respect to alpha and beta cleavages and is able to undergo gamma-processing, which is sensitive to inhibition by DFK167 (28). Co-expression of APPϵ and TMP21 resulted in the accumulation of membrane-embedded higher molecular weight Abeta-positive fragments, consistent with an inhibition of gamma-secretase cleavage. This reporter system was used to determine the functional domain of TMP21 through the investigation of a series of TMP21-p24a chimera proteins. In addition, a synthetic peptide corresponding to the TMP21 transmembrane helix but not the p24a TM domain was able to reduce Abeta secretion in a dose-dependent fashion. These observations indicate that the transmembrane domain of TMP21 is a primary site of action, and its physical association with the presenilin complex can alter gamma-cleavage.
###end p 8
###begin title 9
EXPERIMENTAL PROCEDURES
###end title 9
###begin title 10

###end title 10
###begin title 11

###end title 11
###begin title 12
Mutagenesis and cDNA Constructs
###end title 12
###begin p 13
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 449 454 <span type="species:ncbi:9606">human</span>
TMP21 and p24a tagged at the C-terminal with the FLAG epitope were cloned in pcDNA4 as previously described (26). Chimera constructs between TMP21 and p24a cDNA were obtained following a three-step PCR protocol as previously described (36), and then all constructs were confirmed by DNA sequencing and cloned in pcDNA4 vector with the FLAG epitope at the C terminus. APPϵ constructs containing a stop codon at the end of the transmembrane domain of human APP (isoforms corresponding to 695 or 751) were cloned in pcDNA3 as previously described (28). The wild-type APP constructs (APP WT isoforms 695 or 751) were cloned into pcDNA3.
###end p 13
###begin title 14
Cell Culture, Transfection, and Treatment
###end title 14
###begin p 15
###xml 193 199 <span type="species:ncbi:9913">bovine</span>
Native HEK293 cells or stably transfected HEK293 cells expressing the Swedish APP mutant (APPSwe) were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum. Transient transfections were performed in native HEK293 cells by using Lipofectamine 2000 (Invitrogen) or FuGENE 6 (Roche Applied Science) according to the manufacturer's instructions, and then cells were collected 24-48 h after transfection.
###end p 15
###begin title 16
Membrane Fraction Preparation and Immunoprecipitation
###end title 16
###begin p 17
###xml 60 61 60 61 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 80 81 80 81 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 93 94 93 94 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 293 294 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 480 481 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 501 502 486 487 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 512 513 497 498 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 825 826 809 810 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 847 848 831 832 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 858 859 842 843 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1197 1202 <span type="species:ncbi:10090">mouse</span>
###xml 1250 1255 <span type="species:ncbi:10090">mouse</span>
HEK293 cells were harvested and homogenized in buffer A (5 mm HEPES, pH 7.4, 1 mm EDTA, 0.25 m sucrose, protease inhibitor mixture from Roche Applied Science). The homogenate was clarified by centrifugation at 1000 x g for 5 min at 4 degreesC, and the supernatant was centrifuged at 100,000 x g for 1 h at 4 degreesC. For immunoprecipitation of the intracellular Abeta long species, cell pellets or membrane pellets were homogenized in radioimmune precipitation assay buffer (50 mm Tris, pH 7.4, 150 mm NaCl, 1 mm EDTA, 1% Triton, 0.5% deoxycholate, 0.1% SDS, protease inhibitor mixture). Isolates of either total lysate (2.5 mg) or membrane fraction (800 mug) were diluted in 1 ml of radioimmune precipitation assay buffer. For immunoprecipitation of presenilin complexes, membrane pellets were homogenized in buffer B (25 mm HEPES, pH 7.4, 150 mm NaCl, 2 mm EDTA, 1% CHAPSO, protease inhibitor mixture). Isolates of the membrane fraction (800 mug) were diluted in 1 ml of buffer B to a final concentration of 0.5% CHAPSO. After preclearing with protein G-Sepharose 4 fast flow (GE Healthcare) for 1 h at 4 degreesC, lysates were subjected to immunoprecipitation with the appropriate antibody (a mouse monoclonal anti-Abeta 6E10 (from Covance) or a mouse monoclonal anti-FLAG (from Sigma) antibodies). Immunoprecipitants were recovered by overnight incubation at 4 degreesC with protein G-Sepharose. Beads were washed 3 times with radioimmune precipitation assay buffer or buffer B (0.5% CHAPSO) and once with phosphate-buffered saline.
###end p 17
###begin title 18
SDS/PAGE and Western Blot Analyses
###end title 18
###begin p 19
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 461 467 <span type="species:ncbi:9986">rabbit</span>
Whole cell lysates (total protein 50 mug), membrane lysates (protein 25-50 mug), and immunoprecipitated proteins were dissolved in SDS sample buffer, separated on Tris-Tricine gels 16% or Tris-glycine gels 4-20% (Invitrogen), and transferred to nitrocellulose membranes. Target proteins were visualized by enhanced chemiluminescence (ECL Amersham Biosciences) with the following antibodies: mouse monoclonal anti-Abeta 6E10 (Covance), anti-Abeta 4G8 (Covance), rabbit polyclonal anti-PS1-NTF, anti-NCT-Nt, anti-FLAG (from Sigma), and anti-APP CTF antibodies.
###end p 19
###begin title 20
Peptide Synthesis and Assays
###end title 20
###begin p 21
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
The TMP21 transmembrane domain sequence containing three N- and C-terminal lysine residues (KKK-VLYFSIFSMFCLIGLATWQVFYL-KKK) and the p24a transmembrane domain (KKK-VVLWSFFEALVLVAMTLGQIYYL-KKK) peptides were synthesized by standard Fmoc (N-(9-fluorenyl)methoxycarbonyl)-based solid phase methodology. The terminal lysines were added to increase peptide solubility. Peptides were purified by reverse phase high pressure liquid chromatography using water/acetonitrile mixtures buffered with 0.1% trifluoroacetic acid on a POROS 20R2 column. Stock solutions of both peptides were prepared in DMSO and added at the desired final concentrations (10 and 30 mug/ml) to the media of cultures of HEK293 cells stably expressing the Swedish variant of APP. Media was collected at different time points and Abeta40 levels were determined by ELISA.
###end p 21
###begin title 22
Abeta40 ELISA and Cell-free Assays
###end title 22
###begin p 23
###xml 394 396 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Abeta40 levels were measured by ELISA assays using conditioned medium collected from HEK293 cells after a transient transfection or a treatment with synthetic peptide (TM-TMP21, TM-p24). The enzyme-linked immunoabsorbent assay ELISA was performed according to the manufacturer's instructions (BIOSOURCE. Determination of gamma-secretase activity by cell-free assay was as previously described (26). Briefly, membrane fractions were isolated from HEK293 cells and incubated with recombinant FLAG-tagged APP-C100. TMP21 and p24a synthetic peptides solubilized in DMSO were added to the reaction mixture at the desired concentrations and Abeta40 generated by proteolysis was measured by ELISA.
###end p 23
###begin title 24
Statistical Analysis
###end title 24
###begin p 25
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Statistical analyses were performed with PRISM software (Graph-Pad Software, San Diego. CA) by using the unpaired Student's t test for pairwise comparisons.
###end p 25
###begin title 26
RESULTS AND DISCUSSION
###end title 26
###begin title 27

###end title 27
###begin title 28

###end title 28
###begin title 29
Effects of TMP21 on gamma-Secretase Processing in an APPϵ Reporter Assay
###end title 29
###begin p 30
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 324 326 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 328 330 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 332 334 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 490 496 486 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 496 497 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 606 612 596 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 612 613 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 751 755 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sAPP</italic>
###xml 806 812 774 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 814 815 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 820 821 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1076 1078 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
TMP21 is a type 1 transmembrane protein member of the p24 cargo-protein family that is involved in vesicular targeting and protein transport (29). In addition to its trafficking functions, TMP21 has been shown to specifically regulate proteolysis at the gamma-secretase site, whereas no effects on ϵ-cleavage were observed (26, 27, 30). A C-terminal-truncated APP construct terminating at the ϵ-site was employed to allow investigation of TMP21 activity independent of ϵ-mediated cleavage (Fig. 1A). This APPϵ protein is recognized by an Abeta antibody targeting the N-terminal Abeta residues 1-17 (6E10) (Fig. 1B) and undergoes normal processing by alpha-, beta-, and gamma-secretase to produce similar levels of Abeta peptides and soluble APPalpha (sAPPalpha) fragment in the absence of AICD production (Fig. 1, C and D). Comparable findings have been previously reported which confirm that the APPϵ variant is comparable with the wild-type protein but permits examination of gamma-secretase activities without any complicating factors associated with ϵ-related processing (28).
###end p 30
###begin p 31
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Characterization of the APP&#1013; construct.</bold>
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 122 127 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APPWT</italic>
###xml 257 260 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP</italic>
###xml 431 432 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 576 582 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP FL</italic>
###xml 616 623 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP CTF</italic>
###xml 663 669 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP Ct</italic>
###xml 751 752 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 929 930 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Characterization of the APPϵ construct.A, schematic representation of the wild-type human amyloid-beta precursor protein (APPWT) and its cleavage sites by the indicated secretases. APPϵ corresponds to the N-terminal fragment of APP generated by ϵ-cleavage (APPϵ). 6E10 antibody recognizes the 1-17 sequence of Abeta, 4G8 antibody recognizes the 17-24 sequence of Abeta, and APP C-terminal antibody recognizes the cytoplasmic tail. B, HEK293 cells were transiently transfected with APPWT or APPϵ cDNA as described and analyzed by Western blot for detection of APP full-length (APP FL) or the APP C-terminal fragment (APP CTF) using different APP antibodies (6E10, APP Ct). The APP-CTF-directed antibody does not label APPϵ, which lacks the C terminus. C, medium of HEK293 cells transfected with APPWT or APPϵ cDNA were analyzed by immunoblotting to detect the secreted extracellular fragment soluble APPalpha using 6E10 antibody. D, level of secreted Abeta40 peptide were analyzed by ELISA from medium of HEK293 cells transfected with APPWT or APPϵ cDNA.
###end p 31
###begin p 32
###xml 144 150 144 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 406 408 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 410 412 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 414 416 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 674 680 663 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 680 681 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 699 708 688 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 888 894 871 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 894 895 877 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 912 924 895 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panel</italic>
Co-transfection of APP-WT or APPϵ with C-terminal FLAG-tagged TMP21 resulted in a slight increase in expression levels of full-length proteins (Fig. 2A). A similar minor increase was observed for APP-CTF immunoreactivity in cells overexpressing APP-WT protein. This finding is consistent with previous investigations that demonstrated dual effects of TMP21 on gamma-secretase activity and APP trafficking (26, 27, 30). However, unique effects in gamma-cleavage were observed in cells co-expressing the APPϵ construct with TMP21. Immunoprecipitation and reprobing with an anti-Abeta antibody (6E10 N-terminal epitope) revealed the expected APP-CTF for the wild-type protein (Fig. 2B, short exposure, top panel). Upon longer exposure, two intracellular Abeta-reactive bands were observed in cells expressing APPϵ at higher molecular weights than are seen for the synthetic Abeta40 peptide (Fig. 2B, long exposure, bottom panel). These Abeta-reactive bands accumulated in the cells co-expressing TMP21. These bands were only observed after immunoprecipitation followed by Western blotting, suggesting that they are a small percentage of the total Abeta-related species.
###end p 32
###begin p 33
###xml 0 93 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMP21-induced accumulation of intracellular A&#946;-positive fragments in cells expressing APP&#1013;</bold>
###xml 95 96 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 247 253 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP FL</italic>
###xml 285 292 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP CTF</italic>
###xml 318 319 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 394 399 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP WB</italic>
###xml 559 568 553 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top panel</italic>
###xml 814 826 778 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panel</italic>
TMP21-induced accumulation of intracellular Abeta-positive fragments in cells expressing APPϵ. A, HEK293 cells were transiently co-transfected with TMP21-FLAG and APPWT or APPϵ cDNA, then analyzed by Western blot for detection of full-length APP (APP FL), the APP C-terminal fragment (APP CTF), or TMP21-FLAG protein. B, intracellular Abeta species were immunoprecipitated using 6E10 antibody (IP WB) in HEK293 cells transiently co-transfected with TMP21-FLAG along with APP-WT or APPϵ cDNA, then detected by Western blot using 6E10 antibody (short exposure, top panel). Note the high molecular weight intracellular Abeta at approximately5 kDa recognized by 6E10 antibody in cells overexpressing APPϵ and Abeta-positive bands at approximately6.5 and 5 kDa protected by co-transfection with TMP21 (longer exposure, bottom panel). Synthetic Abeta40 peptide was used as a molecular weight marker and positive control.
###end p 33
###begin p 34
###xml 900 906 862 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 908 909 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 914 915 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1389 1395 1332 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1395 1396 1338 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1615 1621 1550 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1621 1622 1556 1557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
The appearance of these bands suggests that after extracellular cleavage (beta,beta', or alpha cleavage) the gamma-secretase is impaired by TMP21 expression, leading to unprocessed intracellular Abeta species terminating at the ϵ-site (corresponds to Abeta residue 49). The molecular weights of these TMP21-induced bands are in the range of beta-to-ϵ Abeta (residues 1-49; molecular mass, 5.3 kDa) and possibly a beta'-to-ϵ fragment (residues 11-49; molecular mass, 4.1 kDa). These fragments also contained the Abeta N terminus as shown by their reactivity to different antibodies. Abeta-positive species were isolated by immunoprecipitation from cells expressing APPϵ and probed with antibodies recognizing Abeta residues 1-17 (6E10) and 17-24 (4G8). The higher molecular weight bands induced by TMP21 expression were detected by both antibodies and were not seen in control mock-transfected cells (Fig. 3, A and B). These data suggest that the bands are produced by normal cleavage at or near the beta-secretase site and their higher molecular weight as compared with Abeta-(1-40) would be consistent with impaired gamma-processing in the presence of TMP21. The molecular weights of the bands are comparable with that of a synthetic Abeta 1-49 peptide, which indicates that the Abeta-positive fragments would be consistent with an incompletely processed Abeta-containing APPϵ fragments (Fig. 3C). Similar bands were also observed in cells expressing the APPϵ isoform when treated with the gamma-secretase inhibitor, Compound E, which supports the possibility that they are generated by impaired gamma-processing (Fig. 3C).
###end p 34
###begin p 35
###xml 0 139 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Intracellular A&#946;-positive fragments are generated by impaired &#947;-processing and migrate at the level of A&#946;1&#8211;49 synthetic peptides.</bold>
###xml 237 241 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6E10</italic>
###xml 383 384 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 394 395 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 409 410 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 534 535 521 522 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Intracellular Abeta-positive fragments are generated by impaired gamma-processing and migrate at the level of Abeta1-49 synthetic peptides. Intracellular Abeta species were immunoprecipitated from membrane fractions using 6E10 antibody (6E10) in HEK293 cells transiently co-transfected with APPϵ in the presence and absence of TMP21-FLAG, then detected by immunoblotting using 6E10 (A) or 4G8 (B) antibodies. C, HEK293 cells were transfected with APPϵ in the presence or absence of TMP21-TM, then treated or not with Compound E (100 nm). Intracellular Abeta species were then immunoprecipitated and detected using 6E10 antibody. Both TMP21-TM overexpression and Compound E treatment led to an accumulation of Abeta-positive fragment. Synthetic Abeta standard peptides were used as molecular weight markers.
###end p 35
###begin p 36
###xml 447 449 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 664 670 652 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 842 846 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
The fact that these fragments contain the hydrophobic terminus of Abeta was supported by fractionation studies. Membrane and soluble cytosolic fractions from cells expressing APPϵ with or without TMP21 were isolated, and the Abeta-positive species were immunoprecipitated. It should be noted that APPϵ is recovered in the membrane fraction, in agreement with the demonstration that APPϵ behaved as a membrane-bound type 1 protein as does betaAPP (28). Probing with anti-Abeta (6E10) revealed the presence in the membrane fraction but not in the soluble fraction of the high molecular weight, presumably unprocessed fragments that were induced by TMP21 expression (Fig. 4). These findings support the fact that the fragments are membrane-embedded and, therefore, likely contain the APP transmembrane domain terminating at the ϵ-cleavage site (i.e. Abeta49).
###end p 36
###begin p 37
###xml 0 66 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMP21-induced A&#946; species are associated with the lipid bilayer.</bold>
###xml 366 368 363 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
TMP21-induced Abeta species are associated with the lipid bilayer. HEK293 cells were transiently transfected with the APPϵ vector in the presence or absence of wild-type TMP21. Empty vector (pcDNA3) was used as a negative control. Membrane and cytosolic soluble fractions were prepared and probed with anti-FLAG antibodies for TMP21 detection or immunoprecipitated (IP) using anti-Abeta 6E10 and analyzed for detection of intracellular Abeta species. Both TMP21 and Abeta positive fragments were embedded in the membrane. No TMP21 or Abeta-species were detected in the soluble fraction.
###end p 37
###begin p 38
###xml 433 435 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 435 435 417 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32"/>
###xml 436 438 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Taken together, these findings indicate that in the absence of any rate-limiting ϵ-cleavage, TMP21 has a unique effect on gamma-secretase activity, resulting in the accumulation of intracellular membrane-embedded Abeta-related species. These results are reminiscent of recent reports describing an accumulation of intracellular longer Abeta species when gamma-secretase activity is inhibited at the gamma site but not at the ϵ site (31-33). TMP21-mediated gamma-secretase inhibition was seen only with the APPϵ construct, and no significant level of membrane-embedded Abeta-reactive fragments was observed with the co-expression of APP-WT and TMP21. This suggest that one of the main targets for TMP21 may be the membrane-embedded Abeta fragment (residues 1-49) that is generated after release of the AICD cytoplasmic tail. In addition, this finding provides a reporter assay to investigate which domains are responsible for its activity.
###end p 38
###begin title 39
Identification of TMP21 Functional Domains
###end title 39
###begin p 40
###xml 132 134 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 688 694 680 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 694 695 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
The TMP21-related and homologous cargo protein, p24a, was found to be inactive with respect to regulating gamma-secretase activity (26). Therefore, p24a protein was used to create a series of chimera proteins to identify which domains of TMP21 modulate gamma-secretase activity as seen in the APPϵ reporter assay. Chimeras are all FLAG-tagged and included substitution of the transmembrane (TM) and C terminus of TMP21 into p24a (TMP21-TMCt), replacement of the p24a N terminus with the corresponding extracellular domain of TMP21 (TMP21-Nt), replacement of p24a TM with TMP21 (TMP21-TM), and a final construct in which the TMP21 C terminus was inserted into full-length p24a (TMP21-Ct) (Fig. 5A).
###end p 40
###begin p 41
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMP21 interacted with PS-complex through its transmembrane domain.</bold>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 555 557 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
###xml 661 668 661 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PS1-NTF</italic>
TMP21 interacted with PS-complex through its transmembrane domain.A, schematic representation of TMP21-p24a chimera FLAG-tagged proteins indicating the domains (extracellular, TM, and C terminus) of the p24a template, which were replaced with the corresponding TMP21 sequences. B, HEK293 cells were transiently transfected with TMP21, p24a, or chimera proteins. Membrane fractions were prepared and analyzed by Western blot for detection of NCT, PS1-NTF, and FLAG-tagged proteins. C, FLAG-tagged wild-type TMP21-p24a and chimeras were immunoprecipitated (IP) from membrane fractions and analyzed by immunoblotting for detection of NCT, PS1 N-terminal fragment (PS1-NTF), and the FLAG-tagged proteins. Note that only wild-type TMP21 and chimera FLAG proteins containing the transmembrane domain of TMP21 were associated with both NCT and PS1-NTF.
###end p 41
###begin p 42
###xml 223 229 219 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 229 230 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 641 647 637 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 647 648 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 801 807 797 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 807 808 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1015 1021 1011 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1021 1022 1017 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
The chimeras as well as wild-type TMP21 and p24a were transiently expressed in HEK293 cells, and no effects were observed on the levels of gamma-secretase components on the levels of nicastrin maturation or PS1 processing (Fig. 5B). The chimeras all expressed at reasonable levels, suggesting that they were not misfolded or rapidly degraded. Two of the constructs, TMP21-TMCt and TMP21-TM, were found at slightly higher levels as compared with wild-type TMP21 and may, therefore, be well tolerated by the cells. Co-immunoprecipitation studies were conducted for the FLAG-tagged proteins, which successfully pulled down all of the chimeras (Fig. 5C). FLAG-tagged wild-type TMP21 and p24a were used as controls, and as previously reported, TMP21 but not p24a interacts with mature NCT and the PS1-NTF (Fig. 5C). However, significant differences were observed between the chimeras. Association with mature NCT and the PS1-NTF were only found for constructs containing the TM domain of TMP21 (TMP21-TMCt and TMP21-TM; Fig. 5C). In contrast, no binding was observed for chimera containing the N- or C-terminal fragments of TMP21. These observations indicate that the transmembrane domain of TMP21 is essential for its physical interaction with the gamma-secretase complex and may be the primary site of action.
###end p 42
###begin p 43
###xml 270 276 270 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 654 660 651 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 660 661 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1062 1068 1056 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1068 1069 1062 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
To investigate their functional aspects, TMP21 chimeras were co-transfected with APPϵ. Full-length APPϵ was found to be expressed at higher levels for cells co-transfected with wild-type TMP21 or the chimeras TMP21-TMCt or TMP21-TM, containing the transmembrane domain (Fig. 6A). This phenomenon may be the result of the effect of TMP21 on APP trafficking as noted previous (30). Examination of the intracellular Abeta-containing fragments by immunoprecipitation followed by Western blotting revealed that the two higher molecular weight species were only seen for the chimeras containing the TMP21 transmembrane domain (TMP21, TMP21-TMCt, and TMP21-TM, Fig. 6B). This is consistent with the observed interactions of the chimeras with PS1 and NCT which were dependent upon the TMP21 TM domain. The relative intensity of Abeta-positive fragments observed in cells expressing TMP21-TMCt and TMP21-TM chimeras was higher than for the wild-type TMP21. This could be because of slightly higher levels of the chimeras, as FLAG immunoreactivities were more pronounced (Fig. 6A). Alternatively, this may reflect the fact that the chimeric proteins were more readily or efficiently incorporated into the gamma-secretase complexes. Only a small proportion of the full-length TMP21 is incorporated into complexes, and therefore, replacement, for example, of the ectodomain in the chimeras may result in a more accessible conformation for secretase binding.
###end p 43
###begin p 44
###xml 0 57 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#946; production and effects of individual TMP21 domains.</bold>
###xml 57 58 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 226 232 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APP-FL</italic>
###xml 259 260 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 636 637 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 859 867 847 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMP21-Nt</italic>
###xml 898 906 886 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMP21-Ct</italic>
###xml 1029 1037 1017 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMP21-TM</italic>
Abeta production and effects of individual TMP21 domains.A, HEK293 cells were transiently co-transfected with TMP21-FLAG and APPϵ. Membrane fraction were prepared and analyzed by Western blot for detection of APP holoprotein (APP-FL) and TMP21-FLAG proteins. B, intracellular Abeta species were immunoprecipitated using 6E10 antibody in HEK293 cells transiently co-transfected with TMP21-FLAG and APPϵ and subsequently probed with the 6E10 antibody. Only TMP21 and chimera FLAG proteins containing the transmembrane domain of TMP21 resulted in the accumulation of the membrane-embedded higher molecular weight Abeta-positive fragments. C, HEK293 cells were co-transfected with APPϵ and TMP1-p24a chimeras, and Abeta40 levels were determined by ELISA. No changes were observed for full-length TMP21 or p24 and chimeras containing the extracellular N terminus (TMP21-Nt) or intracellular C terminus (TMP21-Ct) of TMP21. Significant reduction was observed for cells expressing the chimera containing the TMP21 transmembrane domain (TMP21-TM).
###end p 44
###begin p 45
###xml 473 479 461 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 479 480 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 718 720 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 722 724 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
Appearance of the Abeta-positive fragments suggests that they may result from a decreased processing of the APP-CTF. It would, therefore, be predicted that a corresponding decrease in Abeta secretion would be seen under these conditions. However, a more complex response was associated with TMP21 and the chimera proteins with respect to Abeta production. Overexpression of full-length wild-type TMP21 and APPϵ did not result in any significant change in Abeta production (Fig. 6C). Levels were comparable with controls as well as cell transfected with the p24a homolog. This is consistent with other studies in whole cells where high levels of TMP21 were also shown to not have an appreciable effect on Abeta levels (26, 27). Therefore, the Abeta-positive fragments must represent only a small percentage of the total Abeta. This could be because of a limited incorporation of full-length TMP21 into mature complexes. Similar issues with incorporation into functional complexes are seen for NCT, which is also not readily assembled into active complexes and accumulates as the immature species.
###end p 45
###begin p 46
###xml 211 217 208 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 217 218 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 365 371 347 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 371 372 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
For the chimera proteins, expression of constructs containing the N-terminal ectodomain (TMP21-Nt) or the intracellular cytoplasmic tail (TMP21-Ct) did not result in any appreciable changes in Abeta production (Fig. 6C). In contrast, expression of the chimera containing the TMP21 transmembrane domain (TMP21-TM) with APPϵ reduced Abeta levels by approximately65% (Fig. 6C). The double-chimera TMP21-TMCt also reduced Abeta levels below that of the TMP21-Nt and TMP21-Ct constructs, consistent with their binding to PS1 and NCT (data not shown). The ability of the TMP21-TM-containing chimera was a consistent observation which suggests that the transmembrane domain has a more pronounced effect than full-length TMP21. The reason for this is unclear, but it is possible that the other domains (N and C termini) regulate other functions such as trafficking or binding to the gamma-secretase complex. Therefore, replacement of these domains may result in a more potent activity of the TMP21 transmembrane region.
###end p 46
###begin p 47
###xml 538 540 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 542 544 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 546 548 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
TM-containing chimeras binding to the gamma-complex may represent one of their mechanisms of action. However, the chimeras also consistently increased the levels of full-length APPϵ precursor. This could provide another explanation for the accumulation of the Abeta-positive fragments and possibly changes in Abeta levels. Based upon these observations, either of the two functional aspects of TMP21, inhibition of gamma-secretase cleavage or changes in APP metabolism, may be responsible for the alterations in Abeta-related processing (26, 27, 30). To try and dissect these two functions, direct interaction of the TMP21 transmembrane domain to the gamma-secretase complex and its ability to alter cleavage were investigated using synthetic peptides in cell culture and cell-free assays.
###end p 47
###begin title 48
Effects of a Synthetic Transmembrane Domain on Abeta Processing
###end title 48
###begin p 49
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 647 653 628 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 653 654 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 919 925 883 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 925 926 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1332 1336 1290 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 1596 1602 1553 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1602 1603 1559 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1847 1853 1804 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1853 1854 1810 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 2302 2304 2245 2247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
The TM domains of TMP21 and p24a were synthesized with three additional lysine residues attached at both the N and C termini to increase solubility. This approach has been used previously for investigations into the membrane insertion and structure of the APP transmembrane helix (34). The TMP21 TM peptide (KKK-VLYFSIFSMFCLIGLATWQVFYL-KKK) solubilized in DMSO was added at different concentrations to cells expressing the APP-Swedish variant, and Abeta40 secretion was measured in medium by ELISA analysis. After incubation for 8 h, cells exposed to 10 mug/ml (final media concentration) of the TMP21 peptide reduced Abeta40 by approximately17% (Fig. 7A). A dose response was observed at 30 mug/ml peptide which produced an approximately32% reduction in Abeta secretion. The corresponding p24a transmembrane peptide (KKK-VVLWSFFEALVLVAMTLGQIYYL-KKK) had no statistically significant effects at either 10 or 30 mug/ml (Fig. 7A). The reduction of Abeta levels was also not because of an inherently toxic effect of the TMP21 peptide that may have led to loss of production because of cell death. Viability assays indicated that no cell toxicity was associated with either the TMP21 or p24a peptides at the concentrations investigated (). The reduced Abeta40 trend for cells treated with the TMP21 peptide at longer conditioning time (e.g. 16 h) remained the same with comparable dose-dependent decreases for treatments with 10 and 30 mug/ml (data not shown). Treatment of cells expressing APPϵ with the TMP21-TM synthetic peptide demonstrated a similar increase in the antibody-positive fragments (Fig. 7B). These fragments were identical to those seen after transfection of the TMP21-TM construct or wild-type protein. No change in these antibody-positive fragments was observed after treatment with the comparable p24a-TM peptide or DMSO control (Fig. 7B). These observations suggest that, in addition to its effects on APP metabolism, TMP21 can directly alter gamma-secretase activity. Given the specific ability of the synthetic TMP21 transmembrane domain to decrease Abeta40 production, it is likely that the peptide associates with the gamma-secretase complex and reduces proteolysis. These observations are consistent with the effects of recombinant TMP21 on Abeta processing as shown previously (26).
###end p 49
###begin p 50
###xml 0 66 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Synthetic transmembrane domain of TMP21 reduced A&#946;40 secretion.</bold>
###xml 66 67 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 505 506 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1024 1025 1001 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
Synthetic transmembrane domain of TMP21 reduced Abeta40 secretion.A, HEK293 cells stably overexpressing APPsw were treated with the synthetic transmembrane domain of TMP21 or p24a (0, 10, 30 mug/ml), and levels of secreted Abeta40 peptide were analyzed by ELISA after 8 h of incubation. The synthetic peptide corresponding to the TMP21 transmembrane domain decreased Abeta40 processing and secretion in a dose-dependent manner. No significant effects were observed for the related p24a TM domain peptide. B, HEK293 cells were transfected with APPϵ, and 8 h before harvesting cells were treated with TMP21 or p24a transmembrane peptides (30 mug/ml) or a DMSO control. Intracellular Abeta species were immunoprecipitated and detected using 6E10 antibody. Treatment with the TMP21-TM peptide only resulted in the accumulation of Abeta-positive fragments. Synthetic Abeta standard peptides were used as molecular weight markers confirmed that the fragments had molecular weights corresponding to Abeta1-49 and related peptides. C, cell-free assays were conducted using membrane preparations from HEK293 cells with recombinant APP-C100 as the gamma-secretase substrate. Synthetic peptides corresponding to transmembrane domains of TMP21 and p24a were added to final concentrations of 0, 10, 30, and 60 mug/ml to the reaction mixture.
###end p 50
###begin p 51
###xml 512 518 501 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 518 519 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 642 648 627 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 648 649 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 955 961 921 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 961 962 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
Cell-free gamma-secretase assays were also conducted in an effort to support these findings and investigate the activity of the synthetic TM peptides. Membrane fractions were prepared from HEK293 cells and incubated with the synthetic TM peptides at various concentrations. Recombinant C100 protein was added to the reaction mixture, and Abeta production was assayed by ELISA. Incubation of membranes with the TMP21 or p24a transmembrane peptides at 10 mug/ml did not have any detectable effect on Abeta levels (Fig. 7C). The TMP21 peptide had a modest effect at 30 mug/ml which resulted in approximately a 10% reduction in Abeta production (Fig. 7C). A more pronounced decrease in Abeta was observed for membranes incubated with 60 mug/ml of the TMP21 TM peptide which resulted in an approximately50% reduction in Abeta processing. This was specific for the TMP21 peptide, as no significant difference was observed for the corresponding p24a TM peptide (Fig. 7C).
###end p 51
###begin p 52
Relatively higher concentrations of the TMP21 transmembrane peptide were required in the cell-free assay to produce the same decrease in Abeta processing as compared with the live cell cultures. This may be because of the fact that the level of the C100 substrate is much higher in the cell-free assay. Therefore, if the TMP21 binds to the gamma-secretase complex as proposed, then the higher amount of substrate could compete for binding sites in the gamma-complex. As a result, increased amounts of the TMP21 transmembrane peptide would be required to displace and/or compete with the C100 substrate.
###end p 52
###begin p 53
###xml 465 467 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
Taken together, these observations have demonstrated that TMP21 expression has a unique effect on gamma-secretase processing when examined in the absence of a possibly competing ϵ-mediated proteolysis. This was evident by the effects seen with the truncated APPϵ which led to the accumulation of Abeta-containing membrane-embedded fragments. Because the AICD sequence, which is lacking in APPϵ construct, contains the YENP motif, essential for APP internalization (35), it is possible to envisage that TMP21 acts on gamma-secretase activity and upstream APP recycling and preferentially targets the membrane-embedded Abeta fragment released after the ϵ-cleavage. However, this remains speculative, and the exact site of the twin function of TMP21 in terms of gamma-secretase modulation and APP metabolism has yet to be elucidated. The direct activity of TMP21 on gamma-secretase appeared to be primarily mediated by its transmembrane domain. It is likely that specific residues are responsible for these effects, and further mutagenesis studies may shed more light on this issue. However, the ability of the TMP21 peptide to alter APP processing and Abeta production could represent a novel strategy for modulating amyloid production and its subsequent pathology.
###end p 53
###begin title 54
Supplementary Material
###end title 54
###begin title 55
Supplemental Data
###end title 55
###begin p 56
This work was supported by grants from the Canadian Institutes of Health Research, Howard Hughes Medical Institute, Alzheimer Society of Ontario, The Ontario Research and Development Challenge Fund and the Canada Foundation for Innovation, the Fondation pour la Recherche Medicale, and the Conseil General des Alpes Maritimes.
###end p 56
###begin p 57
The on-line version of this article (available at ) contains .
###end p 57
###begin p 58
###xml 28 33 28 30 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">A&#946;</term>
###xml 33 53 30 47 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">amyloid &#946;-peptide</p>
###xml 33 53 30 47 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">amyloid &#946;-peptide</p></def>
###xml 28 53 28 47 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">A&#946;</term><def><p textid="59">amyloid &#946;-peptide</p></def></def-item>
###xml 53 56 47 50 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">APP</term>
###xml 56 86 50 77 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">amyloid-&#946; precursor protein</p>
###xml 56 86 50 77 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="60">amyloid-&#946; precursor protein</p></def>
###xml 53 86 47 77 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">APP</term><def><p textid="60">amyloid-&#946; precursor protein</p></def></def-item>
###xml 86 90 77 81 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">AICD</term>
###xml 90 128 81 119 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">cytosolic amyloid intracellular domain</p>
###xml 90 128 81 119 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="61">cytosolic amyloid intracellular domain</p></def>
###xml 86 128 77 119 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">AICD</term><def><p textid="61">cytosolic amyloid intracellular domain</p></def></def-item>
###xml 128 130 119 121 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">PS</term>
###xml 130 140 121 131 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="62">presenilin</p>
###xml 130 140 121 131 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="62">presenilin</p></def>
###xml 128 140 119 131 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">PS</term><def><p textid="62">presenilin</p></def></def-item>
###xml 140 142 131 133 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">TM</term>
###xml 142 155 133 146 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="63">transmembrane</p>
###xml 142 155 133 146 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="63">transmembrane</p></def>
###xml 140 155 131 146 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">TM</term><def><p textid="63">transmembrane</p></def></def-item>
###xml 155 158 146 149 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">NCT</term>
###xml 158 167 149 158 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">nicastrin</p>
###xml 158 167 149 158 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="64">nicastrin</p></def>
###xml 155 167 146 158 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">NCT</term><def><p textid="64">nicastrin</p></def></def-item>
###xml 167 169 158 160 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">WT</term>
###xml 169 178 160 169 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="65">wild type</p>
###xml 169 178 160 169 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="65">wild type</p></def>
###xml 167 178 158 169 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">WT</term><def><p textid="65">wild type</p></def></def-item>
###xml 178 184 169 175 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">CHAPSO</term>
###xml 184 255 175 246 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="66">3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid</p>
###xml 184 255 175 246 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="66">3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid</p></def>
###xml 178 255 169 246 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">CHAPSO</term><def><p textid="66">3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid</p></def></def-item>
###xml 255 262 246 253 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">Tricine</term>
###xml 262 263 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 262 310 253 301 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="67"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p>
###xml 262 310 253 301 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="67"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p></def>
###xml 255 310 246 301 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">Tricine</term><def><p textid="67"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p></def></def-item>
###xml 310 313 301 304 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">NTF</term>
###xml 313 332 304 323 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="68">N-terminal fragment</p>
###xml 313 332 304 323 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="68">N-terminal fragment</p></def>
###xml 310 332 301 323 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">NTF</term><def><p textid="68">N-terminal fragment</p></def></def-item>
###xml 332 334 323 325 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">Nt</term>
###xml 334 344 325 335 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="69">N terminus</p>
###xml 334 344 325 335 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="69">N terminus</p></def>
###xml 332 344 323 335 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">Nt</term><def><p textid="69">N terminus</p></def></def-item>
###xml 344 346 335 337 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G12">Ct</term>
###xml 346 356 337 347 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="70">C terminus</p>
###xml 346 356 337 347 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="70">C terminus</p></def>
###xml 344 356 335 347 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G12">Ct</term><def><p textid="70">C terminus</p></def></def-item>
###xml 356 361 347 352 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G13">ELISA</term>
###xml 361 395 352 386 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="71">enzyme-linked immunosorbent assay.</p>
###xml 361 395 352 386 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="71">enzyme-linked immunosorbent assay.</p></def>
###xml 356 395 347 386 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G13">ELISA</term><def><p textid="71">enzyme-linked immunosorbent assay.</p></def></def-item>
###xml 28 395 28 386 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">A&#946;</term><def><p textid="59">amyloid &#946;-peptide</p></def></def-item><def-item><term id="G2">APP</term><def><p textid="60">amyloid-&#946; precursor protein</p></def></def-item><def-item><term id="G3">AICD</term><def><p textid="61">cytosolic amyloid intracellular domain</p></def></def-item><def-item><term id="G4">PS</term><def><p textid="62">presenilin</p></def></def-item><def-item><term id="G5">TM</term><def><p textid="63">transmembrane</p></def></def-item><def-item><term id="G6">NCT</term><def><p textid="64">nicastrin</p></def></def-item><def-item><term id="G7">WT</term><def><p textid="65">wild type</p></def></def-item><def-item><term id="G8">CHAPSO</term><def><p textid="66">3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid</p></def></def-item><def-item><term id="G9">Tricine</term><def><p textid="67"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p></def></def-item><def-item><term id="G10">NTF</term><def><p textid="68">N-terminal fragment</p></def></def-item><def-item><term id="G11">Nt</term><def><p textid="69">N terminus</p></def></def-item><def-item><term id="G12">Ct</term><def><p textid="70">C terminus</p></def></def-item><def-item><term id="G13">ELISA</term><def><p textid="71">enzyme-linked immunosorbent assay.</p></def></def-item></def-list>
The abbreviations used are: Abetaamyloid beta-peptideAPPamyloid-beta precursor proteinAICDcytosolic amyloid intracellular domainPSpresenilinTMtransmembraneNCTnicastrinWTwild typeCHAPSO3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acidTricineN-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycineNTFN-terminal fragmentNtN terminusCtC terminusELISAenzyme-linked immunosorbent assay.
###end p 58
###begin p 59
amyloid beta-peptide
###end p 59
###begin p 60
amyloid-beta precursor protein
###end p 60
###begin p 61
cytosolic amyloid intracellular domain
###end p 61
###begin p 62
presenilin
###end p 62
###begin p 63
transmembrane
###end p 63
###begin p 64
nicastrin
###end p 64
###begin p 65
wild type
###end p 65
###begin p 66
3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonic acid
###end p 66
###begin p 67
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine
###end p 67
###begin p 68
N-terminal fragment
###end p 68
###begin p 69
N terminus
###end p 69
###begin p 70
C terminus
###end p 70
###begin p 71
enzyme-linked immunosorbent assay.
###end p 71
###begin title 72
REFERENCES
###end title 72

